omniture
皓天策略投资顾问(深圳)有限公司

Latest News

Treadwell Therapeutics Announces the Appointment of J.D. Mowery, as Chief Operating Officer

NEW YORK and HONG KONG, April 20, 2022 /PRNewswire/ -- Treadwell Therapeutics (" Treadwell"), a clin...

2022-04-20 04:30 1919

HUANENG POWER INTERNATIONAL, INC. DOMESTIC ON-GRID ELECTRICITY IN THE FIRST QUARTER OF 2022 INCREASED BY 2. 42% YEAR-ON-YEAR

BEIJING, April 14, 2022 /PRNewswire/ -- Huaneng Power International, Inc. ("HPI", the "Company") (N...

2022-04-14 23:40 1959

Treadwell Therapeutics and University Health Network Sign Licensing Agreement for pre-clinical biologic and small molecule assets

NEW YORK, HONG KONG and TORONTO, April 6, 2022 /PRNewswire/ -- Treadwell Therapeutics today announc...

2022-04-06 20:59 1950

Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US

SHENZHEN, China and LEIDEN, Netherlands, April 6, 2022 /PRNewswire/ -- Shenzhen Pregene Biopharma, ...

2022-04-06 20:30 1762

CMGE Announces 2021 Annual Results

The IP Game Ecosystem was Very Competitive Continued Expansion of User Scale and Steady Growth in R...

2022-04-01 14:00 5309

CPIC Announces 2021 Sustainability Report

HONG KONG, March 31, 2022 /PRNewswire/ -- On March 27, China Pacific Insurance (Group) Co., Ltd.("C...

2022-03-31 17:38 3879

CPIC Announces 2021 Annual Results

HONG KONG, March 28, 2022 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd.("CPIC" or the "...

2022-03-28 21:46 3326

HUANENG POWER INTERNATIONAL, INC. NET LOSS ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY IN 2021 AMOUNTED TO RMB 10.636 BILLION YEAR-ON-YEAR DECREASE 547.27%

BEIJING, March 22, 2022 /PRNewswire/ -- Huaneng Power International, Inc. (hereinafter referred to ...

2022-03-23 01:06 2403

Industry Service Innovation Case Selection Results Released - 11 Cases of "CPIC Service" Like to Mention Four Awards

HONG KONG, March 17, 2022 /PRNewswire/ -- Recently, the "2021 banking and insurance service innovat...

2022-03-17 17:28 2577

MediTrust Health invited three women who are fighting with diseases to share their views for March 8th Women's Day

SHANGHAI, March 8, 2022 /PRNewswire/ -- As the Women's Day is approaching, MediTrust Health invited...

2022-03-08 18:22 1730

New Subsidiary, New Advantage

HONG KONG, March 1, 2022 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd.("CPIC" or the "C...

2022-03-02 10:54 4678

Rare Disease Day | With iCare, Love is Not Rare, MediTrust Health - iCare Clover Gives Care and Protection to Rare Disease Patients

SHANGHAI, March 1, 2022 /PRNewswire/ -- "When Zixu was about 10 months old, he already seemed diffe...

2022-03-01 20:05 1693

CPIC Gathers Pace in Serving Asian Games

HONG KONG, Feb. 25, 2022 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd.("CPIC" or the "C...

2022-02-25 17:52 4440

JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA

SHANGHAI, Feb. 16, 2022 /PRNewswire/ -- Ji Xing Pharmaceuticals Limited (JIXING), a clinical-stage ...

2022-02-16 18:06 2530

THOROUGH PRACTICE OF ESG CONCEPTS AND STEADY PROMOTION OF THE BIG HEALTH STRATEGY

HONG KONG, Jan. 31, 2022 /PRNewswire/ -- The brand value of China Pacific Insurance (Group) Co., Lt...

2022-01-31 21:21 6712

CPIC RANKS FIFTH IN TERMS OF GLOBAL INSURANCE BRAND VALUE

HONG KONG, Jan. 31, 2022 /PRNewswire/ -- On January 26, Brand Finance, the world's authoritative br...

2022-01-31 21:19 5191

Novotech Completes $255M Private Placement Transaction and $505M Refinancing to Accelerate Implementation of Growth Initiatives

SINGAPORE and SYDNEY, Jan. 19, 2022 /PRNewswire/ -- Novotech Health Holdings Pte. Ltd. ("Novotech H...

2022-01-19 16:38 2046

Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor

NEW YORK and HONG KONG, Dec. 8, 2021 /PRNewswire/ -- Treadwell Therapeutics, today announced a pres...

2021-12-08 20:00 2436

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257

NEW YORK and HONG KONG, Nov. 30, 2021 /PRNewswire/ -- Treadwell Therapeutics, a clinical stage biot...

2021-11-30 20:00 2781

Tongcheng-Elong Announces 2021Q3 Results Securing the Leadership in the Industry and Seizing New Opportunities in the Market

HONG KONG, Nov. 22, 2021 /PRNewswire/ -- Tongcheng-Elong Holdings Limited (" Tongcheng-Elong" or the...

2021-11-22 20:54 3369
12345